Locus To Raise $25 Million

Locus Pharmaceuticals Inc., a Blue Bell, Pa.-based small-molecule drug company, is looking to raise $25 million in Series E funding, according to VentureWire. It already has raised over $92 million in total VC funding since its 1999 inception, including a $40 million Series D round at a post-money valuation of approximately $196 million.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />